WHO ICTRP trial
Does the eradication of endoparasites promote allergic disease?
ISRCTN71058787 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN71058787 |
|---|---|
| Public title | Does the eradication of endoparasites promote allergic disease? |
| Primary sponsor | University of Nottingham (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | Viet Nam |
| Conditions | Allergic disease, soil-transmitted helminths Skin and Connective Tissue Diseases Allergic disease |
| Interventions | The original study protocol used three-monthly single dose Mebendazole 500 mg over one year. After the first treatment round, investigators noticed low efficacy of this regime. Therefore, a treatment comparison study was conducted to select… |
| Registration date | Nov 15, 2005 |
| Target size | 1600 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: